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Objective: Sexually transmitted diseases (STDs) constitute a major public health concern in developing countries. 
Their interest lies mainly in their diagnosis and their early treatment. Owing to lack of health education and poor 
living conditions inherent in underdevelopment, self-medication is common practice in these Third World countries. 
Therefore, the illegal sale of drugs is an important phenomenon in Africa and Asia. 
Methods: An investigation, with a view to evaluating the importance of drug sales in the parallel market for the 
treatment of urethral discharge in Dakar, was carried out in 50 different locations in the working-class districts of 
the capital from 13 February to 6 March 1997. These drugs, obtained from vendors in the illegal market, were tested 
and analyzed using the standard physicochemical methods. 
Results: The most frequently proposed drugs to treat male urethritis are: ampicillin 250-mg capsules (44%); 
oxytetracyline 250-mg capsules (24%); and cotrimoxazole 450-mg tablets (12%). In most cases (88%) these drugs 
were sold unpackaged; 12% were sold in blisters. Furthermore, in 90% of cases, the expiry date was not indicated. 
The dosage and duration of treatment were correct in only 6% of cases. The physicochemical analysis was based on 
the external appearance, the identification, and the dosage of the active principle. Of these drugs offered by street 
vendors, 53.1% had an unusual appearance; they were mainly ampicillin 250 mg (21 of 22 samples) and oxytetra- 
cycline 250 mg (6 of 12 samples). Furthermore, all active principles were identified as positive, with the exception of 
ampicillin 250 mg, for which only one sample of the 22 was positive; the others appeared to be flour, with no trace 
of the active principle. 
Conclusion: Given the extent of these illegal sales of drug and their harmful consequences for the health of the 
population, adequate measures should be taken to eradicate this blight. For this mission to succeed, public authorities, 
health professionals and populations should combine their efforts. 
Int J Infect Dis 2002; 6: 108-112 
INTRODUCTION 
STDs represent a major public health concern. Accord- 
ing to the WHO, 685 000 new cases of STD are recorded 
each day worldwide.’ 
They are also among the main causes of morbidity, 
due to serious complications such as male and female 
sterility, ectopic pregnancy, urethral stricture and genital 
cancer.The interaction of STDs and HIV is now proven, 
and aggravates the mortality and morbidity potential. 
They therefore need to be diagnosed and treated very 
early. But in developing countries, there exists a problem 
of accessibility to care and of ignorance in terms of 
health education, which drives the populations to self- 
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medication and treatment outside of health facilities. In 
certain African countries, despite the possibility of 
obtaining drugs in private pharmacies and the setting up 
of policies for access to essential drugs in health facilities, 
the parallel selling of drugs is still significant. In Dakar, 
the illegal sale of drugs is a well-developed practice, and 
for this reason we set ourselves the following objectives 
in this study: 
1. Identify the different selling points outside of official 
structures. 
2. Evaluate the level of knowledge that the drug vendors 
in the parallel market in Dakar have about STDs. 
3. Analyze the physical and chemical qualities of those 
drugs proposed for the treatment of STDs in the 
parallel market. 
MATERIALS AND METHODS 
To attain these objectives, we carried out an investi- 
gation in the urban and suburban areas of Dakar. This 
investigation was carried out in the different markets 
in Dakar, where the sale of drugs has progressively 
increased during the past decade. Vendors are usually 
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RESULTS 
The investigation was carried out in 50 locations where 
drugs to treat urethral discharge were sold.The majority 
of samples were from the suburbs of Dakar, i.e. 52% of 
investigated parallel markets and 48% from the city of 
Dakar. At 85% of selling points, drugs were sold on 
tables exposed to the sun. The most frequently pre- 
scribed drugs by the vendors in the parallel market 
for the treatment of urethral discharge are: ampicillin 
250 mg (44%), oxytetracycline 250 mg (24%), and co- 
trimoxazole 480 mg (12%) (Table 1). 
These drugs are, in 88% of cases, sold unpackaged; 
12% are sold in blisters (6 investigated locations out of 
50). Furthermore, in 90% of cases, the expiry date was 
not indicated for those drugs offered for the treatment 
of urethral discharge in the parallel market in Dakar. 
The dosage for the treatment of urethritis was correct 
for only 3 of 50 prescribed samples, i.e. 6%. 
The duration of the treatment for male urethritis 
proposed by the vendor in the parallel market was con- 
sidered sufficient when it lasted between 5 and 7 days, 
from the rural area and possess stalls filled with various Table 1. Distribution of drugs offered in the parallel market 
drugs, including antibiotics. The present study was for the treatment of urethral discharge 
carried out from 13 February to 6 March 1997 in the Drug Number Percentage 
form of an investigation through interviews with drug 
vendors in the parallel market.The study concerns anti- Ampicillin 250 mg 
22 44 
Oxytetracycline 250 mg 12 24 
biotics and other drugs offered by vendors for the Cotrimoxazole 480 mg 6 12 
treatment of urethral discharge. We introduced our- Ampicillin 500 mg - 5 10 
selves, without medical prescription, as suffering from Penicillin V 1 000 000 UI 2 
4 
2 
purulent urethral discharge.The vendor was then invited 
lndomethacin 25 mg 1 
Niflunic acid 250 mg 1 2 
to advise on an appropriate medication, indicating the Nitroxoline 100 mg 1 2 
dosage, duration of treatment and cost. We took the Tota I 50 100 
opportunity to collect information on packaging, expiry 
dates and the average number of people who come for 
STD treatment per day. The vendor made a prescription Table 2. Distribution of samples according to the duration 
in which we had no say. In the event where he could proposed for the treatment of urethritis 
not treat the disease, we took leave of him. The WHO Duration of Treatment Number Percentage 
standards* with regard to the dosage and the duration of 
treatment for urethritis were retained as reference values Insufficient 40 80 
(without taking into account the gonococcic etiology 
Sufficient 9 18 
Excessive 1 2 
or not of the urethritis in the absence of laboratory 
analyses). The drugs proposed by the vendor for the 
Total 50 100 
treatment of the STD were kept in clean tubes for later 
physicochemical analyses carried out by the Parke 
Davis control laboratory, a pharmaceutical industry 
located in the industrial zone in Dakar. The physical 
analysis consisted of assessing the external appearance 
of the drug, the time it took to disintegrate, and its 
weight. For the chemical analysis, the methods used, 
such as oxidation-reduction, electrochemistry and 
chromatography, enabled us to identify the nature of 
the product proposed by the vendor and determine the 
dosage of the active principle. The Parke Davis labora- 
tory provided the reference molecule for the chemical 
analysis. Data input and analysis were done with the 
help of the Epi info 6.0 software. 
insufficient when it was less than 3 days, and excessive 
when it was more than 10 days (reference WHO 
standards). In this study, the duration of the treatment 
of urethral discharge was insufficient in 80% of cases 
(Table 2). 
The number of clients per day with urethral dis- 
charge who visited a drug vendor in the parallel market, 
in the working-class districts of Dakar, varied between 
2 and 15, with a mode of 5 (in 58.3% of cases). 
The cost of the treatment of urethritis in these 
parallel markets varied from 100 to 2800 CFA francs 
(1 CFA franc=O.Ol FF). It was 600 CFA francs (1 
US$=600 CFA francs) in 20% of cases. The physico- 
chemical analysis of the drugs offered was based on 
their external appearance, and the identification and 
dosage of the active principle. Of the drugs offered, 
53.1% had an unusual appearance with regard to the 
external color of the molecule; this mainly concerned 
ampicillin 250 mg (21 of 22 samples) and oxytetracycline 
250 mg (6 of 12 samples) (Table 3). 
All the active principles in the drugs offered for the 
treatment of urethritis were identified as positive, with 
the exception of ampicillin 250 mg, for which only one 
of the 22 samples was correct. 
COMMENTS 
Our investigation revealed that the selling of drugs in 
the parallel market is a common practice in Dakar and 
maay well increase in the coming years. Selling points 
are increasing in number. The parallel market, in most 
cases, has developed in the suburbs of Dakar, where 
there is a high population density, due to massive rural 
depopulation. A population with a low income and poor 
living conditions with difficulties in accessing care can 
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Table 3. Distribution of drugs according to their appearance in 
the physical analysis 
Appearance 
Drug Normal Unusual Total 
Ampicillin 250 mg 1 21 22 
Oxytetracycline 250 mg 6 6 12 
Cotrimoxazole 480 mg 6 0 6 
Ampicillin 500 mg 5 0 5 
Penicillin V 2 0 2 
lndomethacin 25 mg 1 0 1 
Niflunic acid 250 mg 1 0 1 
Total 22 27 49 
Table 4. Distribution of drugs according to the identification 
of the active principle in the chemical analysis 
Identification 
identified Identified 
Drug f+J C-J Total 
Ampicillin 250 mg 1 21 22 
Oxytetracycline 250 mg 12 0 12 
Cotrimoxazole 480 mg 6 0 6 
Ampicillin 500 mg 5 0 5 
Penicillin V 2 0 2 
lndomethacin 25 mg 1 0 1 
Niflunic acid 250 mg 1 0 1 
Total 22 27 49 
often be found in these areas. Because of difficulties in 
obtaining financial access to official pharmacies, these 
populations turn to the parallel market to obtain medi- 
cation. These drugs are often sold singly, unpackaged in 
small bottles, thereby posing the problem of conserving 
the active principle contained in the products. It is well 
known that antibiotics are among the most difficult 
drugs to conserve, especially in Africa, because of high 
temperatures and humidity. Their exposure on stalls 
without protection favors the action of bad weather, 
bringing about the denaturation of the active principle 
and consequently of antibacterial activity. A problem 
concerning the quality of these drugs handled daily by 
vendors ignorant of conservation details and expiry 
dates also exists. 
The medication proposed for the treatment of 
urethral discharge in the parallel market comprises 
antibiotics; ampicillin 250 mg, oxytetracycline and CO- 
trimoxazole represent 96% of prescriptions. Anti- 
inflammatories (indomethacin) were prescribed in 2% 
of cases. 
Elsewhere, in a study carried out in Cotonou on 
products sold on the parallel market, Fayomi et al3 noted 
that p-lactams were most popular (4.5%) followed by 
tetracycline (14%) macrolides (lo%), aminoglycosides 
and chloramphenicol (7%). In Niger, anti-STD drugs 
offered in the parallel market are oxytetracycline, 
Aampicillin and macrolides.4 
For most of the products, the expiry date is 
unknown. Of the 50 samples we obtained, only five, i.e. 
lo%, had an expiry date. It is known that consuming 
expired products can have serious consequences: com- 
plications of an untreated STD, resistance to antibiotics, 
and serious clinical signs. The dosage proposed by these 
vendors was incorrect in 94% of cases. It was too low in 
most cases, with only two tablets taken at a time. The 
duration of the treatment, between 1 and 5 days, was 
also insufficient. Neither the dosage nor the duration of 
the treatment were appropriate, and this exposes the 
patient to a high risk of developing resistant organisms. 
For the treatment of gonorrhea, of the 67 vendors 
interrogated at the Dantokpa market in Cotonou, 63 
proposed inappropriate treatment.3 With regard to 
dosage, 85 % of vendors proposed a dose insufficient for 
the treatment of male gonococcic urethritis. Only five 
vendors gave a correct dosage, advising in one case the 
concomitant treatment of the partner. 
In this study, the cost of treatment of urethral 
discharge varied from 100 to 2800 CFA francs, whereas 
in pharmacies it costs on average 7500 CFA francs. A 
medical prescription is needed in the latter case, so a 
medical consultation fee needs to be added, and this 
varies between 1000 CFA francs in public facilities and 
15 000 CFA francs in private practices. A problem of 
financial access to these drugs therefore exists, forcing 
the impoverished populations to turn to the parallel 
markets for medication. In Niger, Niandou4 evaluated 
the cost of one capsule at 10 CFA francs for ampicillin 
capsules as well as tetracycline capsules. The study 
carried out at the Dantokpa market in Cotonou showed 
that the drugs sold on the parallel market cost 10 times 
less than those in the pharmacies. 
With regard to the appearance, 26 of 49 samples 
were unusual, i.e. 53% of cases. Oxytetracycline mole- 
cules are denatured and of a brown color, and of the 22 
ampicillin 250-mg samples, only one had the organo- 
leptic characteristics of the reference molecule; the 
others had the appearance of flour, with no trace of the 
active principle during chemical analysis. Similar results 
have also been obtained in Senegal and other African 
countries.5 In 1993, Mbengue6 noted, in an investigation 
carried out in Dakar on drugs sold on the parallel 
market, that only one of 10 ampicillin samples contained 
the active product. Elsewhere in Niamey, according 
to Niandou4 the ampicillin obtained on the parallel 
market does not have the organoleptic characteristics of 
the reference molecule. 
In a study carried out in Cambodia on the quality of 
drugs sold and handed out, Gimenez et al’ emphasized 
the poor quality of all types of product in the private and 
illegal sector as well as in the public sector. Contrary to 
our study, they noted in Cambodia a low percentage of 
substitution products. 
According to Koch et al8 and Lambert,” the poor 
quality of drugs can be of two types: voluntary 
falsification (absence of the active principle, presence of 
a lesser quantity than indicated, replacement of the 
active principle with a less costly substance) or poor 
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manufacture (a non-homogenous distribution of the 
active principle in the same batch, bioequivalence of a 
generic). This imitation of drugs represents a serious 
public health concern in African countries, due mainly 
to the clandestine importation of these drugs, but also 
due to the absence of quality control laboratories. 
According to WHO estimates, imitations represent 5% 
of the world market, and 30% of these drugs circulate in 
Africa.9 
This illegal sale of drugs is all the more easy and 
intense given that the borders of African countries are 
porous, and the cost of these antibiotics on the parallel 
market is clearly lower than in private pharmacies. 
Faced with such a situation, patients will easily go to the 
markets, where a drug is not only affordable but also 
‘negotiable’. However, this strategy to get treatment at 
a lesser cost exposes people to risks related to the 
consumption of medication of uncertain quality at an 
incorrect dosage. 
Other than the risk of taking under-dosed, deter- 
iorated or expired products, the other consequence of 
the parallel market is self-medication. In fact, it is 
accepted that in Africa, 2040% of self-medication 
concerns antibiotics sold without medical prescriptionlo 
This self-medication may favor the occurrence of 
adverse effects due to ignorance of contraindications 
and especially the risk of bacterial resistance because of 
inappropriate dosage and treatment duration. These 
resistance phenomena represent a major public health 
concern in tropical areas, because of their spread, their 
negative economic impact, and their role in the failure 
of antibiotherapy. In Senegal, in 1996, according to 
Bathily et al,” of 58 samples of Neisseria gonorrheae 
tested, 15 (28.5%) produced penicillinase (GNPP) and 
were totally resistant to penicillin, 31 samples (53.4%) 
were sensitive to tetracycline, and 9 (15.5%) showed a 
high level of resistance through plasmid. This was the 
first time in Senegal that a case of tetracycline-resistant 
Neisseria gonorrheae (GNRT) was reported. Further- 
more, according to these same authors, 56 (96.5%) of 
samples were more sensitive to cotrimoxazole, and no 
resistance to ciprofloxacin and to ceftriaxone were noted. 
In sub-Saharan Africa, 20-80% of gonococcus strains 
are antibiotic resistant, 10-40% through penicillinase 
production.” 
Thus, the current treatment for gonorrhea does not 
rely on the penicillin offered by the vendors in the para- 
llel market, but on inhibitory P-lactams, cephalosporins 
and quinolones.2 
Faced with these dangers, whose importance escapes 
nobody, measures should be taken to try to reduce them 
and give patients quality care. The public and health 
authorities in each country should be the first to engage 
in the fight against illegal drug sales outside of official 
structures. The proposed solutions in the Bamako 
Initiative (BI) could help reduce the negative impact of 
parallel markets. In effect, the BI objective is to attain 
health for all in the year 2000 through a cost reduction 
in consultations and drugs and through favoring 
geographic and financial accessibility of health facilities. 
Also, customs activities to stop the smuggling of drugs 
at the borders should be reinforced by applying the 
appropriate rules and sanctions. Regular monitoring of 
official health facilities is also necessary, taking stock of 
incoming and outgoing drugs whose management is 
entrusted to the health personnel. Pharmaceutical firms 
should be involved in the fight against the illegal traffic 
in drugs. Those whose products are found on the parallel 
market should be informed, so that they can control 
the free distribution of samples, which are sometimes 
sold illegally. They could also contribute by reducing the 
cost of certain antibiotics, given the difficult economic 
situation in developing countries. Informing consumers 
about the dangers of buying drugs outside of official 
structures are also important measures in the fight 
against this blight. 
CONCLUSION 
STDs represent a serious public health concern in 
developing countries. However, despite all the efforts 
deployed in prevention and treatment, there exists 
today the problem of obtaining drugs in the parallel 
market, particularly those for STD treatment. The 
results of different studies carried out on this subject 
have indicated that the parallel market drugs represent 
a serious threat in developing countries. Given the 
extent of this illegal sale of drugs and the harmful 
consequences of using these products, appropriate 
measures should be taken to eradicate this blight. 
For this mission to succeed, the public authorities, 
health professionals and the populations should combine 
their efforts and: 
l carry out information and sensitization campaigns for 
the benefit of the populations, on drugs and on the 
dangers related to drugs sold on the street; 
l promote primary health care and essential drugs; 
l confiscate drugs on the illegal circuit and crack down 
on the perpetrators of such fraudulent acts; 
l create a national drug quality control laboratory. 
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